Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ARENA PHARMACEUTICALS, INC
12/07 ARENA PHARMACEUTICALS : Completes Enrollment in Ralinepag Phase 2 Clinical Trial..
11/30 ARENA PHARMACEUTICALS ANNOUNCES FOUR : Crohn's & Colitis Foundation's Clinical a..
11/09 ARENA PHARMACEUTICALS : to Present at the 28th Annual Piper Jaffray Healthcare C..
11/07 ARENA PHARMACEUTICALS : reports 3Q loss
11/07 ARENA PHARMACEUTICALS : Reports Third Quarter 2016 Financial Results and Provide..
11/07 INVESTIGATION FOR LONG-TERM INVESTOR : ARNA) Announced
11/06 ARENA PHARMACEUTICALS : to Release Third Quarter 2016 Financial Results and Prov..
10/31 ARENA PHARMACEUTICALS : to Release Third Quarter 2016 Financial Results and Prov..
10/11 ARENA PHARMACEUTICALS : Announces Acceptance of Late Breaking Etrasimod Abstract..
10/04 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files an 8k
10/03 EISAI INC. : and Arena Pharmaceuticals Announce Availability of Once-Daily BELVI..
09/01 ARENA PHARMACEUTICALS : Pharmaceutics Announces Formation of Beacon Discovery
08/30 INNOVUS PHARMACEUTICALS : Pharma Appoints Robert Hoffman As EVP And CFO
08/15 ARENA PHARMACEUTICALS : Announces Appointment of Vincent Aurentz as Chief Busine..
08/08 ARENA PHARMACEUTICALS : reports 2Q loss
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
12/07 ARENA PHARMACEUTICALS : Completes Enrollment in Ralinepag Phase 2 Clinical Trial..
11/30 ARENA PHARMACEUTICALS ANNOUNCES FOUR : Crohn's & Colitis Foundation's Clinical a..
11/17 ARENA PHARMACEUTICALS : Reports Third Quarter 2016 Financial Results and Provide..
11/17 ARENA PHARMACEUTICALS : to Present at the 28th Annual Piper Jaffray Healthcare C..
11/09 ARENA PHARMACEUTICALS : to Present at the 28th Annual Piper Jaffray Healthcare C..
11/09 ARENA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
11/08 ARENA PHARMACEUTICALS INC. : (ARNA) is Trading Higher on Unusual Volume for Nove..
11/07 ARENA PHARMACEUTICALS : reports 3Q loss
11/07 ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Finan..
11/07 ARENA PHARMACEUTICALS : Reports Third Quarter 2016 Financial Results and Provide..
More news
Sector news : Biotechnology & Medical Research - NEC
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
11/26 Johnson & Johnson approaches Actelion about takeover deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
12/09 Healthcare bounces back from Trump tantrum
12/07 Arena Pharma completes enrollment in mid-stage ralinepag study in PAH; top-li..
11/29 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi Presents at 28th Annual Piper J..
11/08 ARENA BEATS THE STREET : What Investors Need To Consider
11/07 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi on Q3 2016 Results - Earnings C..
11/07 Arena Pharmaceuticals beats by $0.02, beats on revenue


Advertisement
Financials ($)
Sales 2016 51,7 M
EBIT 2016 -72,8 M
Net income 2016 -82,8 M
Debt 2016 74,0 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 8,07x
EV / Sales 2017 10,1x
Capitalization 343 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 3,75 $
Spread / Average Target 166%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..-27.89%343
QUINTILES IMS HOLDINGS..14.10%19 286
INCYTE CORPORATION-7.21%18 957
CELLTRION, INC.--.--%9 997
LONZA GROUP AG9.20%9 261
SEATTLE GENETICS, INC.44.54%9 183
More Results